Alpas vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Singapore procurement automation platform serving SE Asian manufacturing and construction; YC W21 $2.83M BEENEXT-backed at $4.7M revenue with 3-way PO/delivery/invoice matching for SME purchasing workflows.
About
Alpas is a Singapore-based procurement automation platform — backed by Y Combinator (W21) with $2.83 million raised including a $1.5 million seed round from BEENEXT and Y Combinator in December 2021 — providing manufacturing, construction, and services companies across Southeast Asia with cloud-based purchase order management, supplier management, invoice reconciliation, and spend analytics to replace manual email-and-spreadsheet procurement workflows that dominate SME purchasing in the region. Founded in 2020 and generating $4.7 million in revenue in 2024 with a 31-person team, Alpas serves the procurement digitization need for Southeast Asian businesses that operate in fragmented supplier markets without the ERP procurement modules that large enterprises use.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.